ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Neurology

Top Neurology Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
VENKATACHALAM VEERAPPAN MD

Neurology

5,123

$1.52M

466
262 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$296
Average prescription price

Avg: $272

HOWARD EHRENFELD M.D.

Neurology

4,971

$1.22M

618
477 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$245
Average prescription price

Avg: $272

TIMOTHY DOYLE M.D.

Neurology

3,704

$565K

384
292 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$152
Average prescription price

Avg: $272

MOUCHIR HARB M.D.

Neurology

3,683

$513K

242
93 are 65+

47%
patients receiving schedule two controlled substances

Avg: 3%

26%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $272

SANTOS YU MD

Neurology

3,634

$582K

607
471 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 24%

$160
Average prescription price

Avg: $272

JESUS HERNANDEZ MD

Neurology

3,534

$622K

510
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$176
Average prescription price

Avg: $272

TIMOTHY LOUIE M.D.

Neurology

3,449

$706K

353
219 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$205
Average prescription price

Avg: $272

MELISSA BLOCH M.D.

Neurology

3,358

$820K

206
66 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$244
Average prescription price

Avg: $272

CHARLES BERNICK M.D.

Neurology

2,593

$412K

377
356 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

45%
prescriptions for brand name drugs

Avg: 24%

$159
Average prescription price

Avg: $272

RYAN WALSH MD, PHD

Neurology

2,587

$326K

252
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $272

ERIC FARBMAN M.D.

Neurology

2,456

$818K

273
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$333
Average prescription price

Avg: $272

SHANKER DIXIT M.D.

Neurology

2,290

$629K

492
323 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$275
Average prescription price

Avg: $272

OMAR CABAHUG M.D.

Neurology

2,086

$651K

372
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

44%
prescriptions for brand name drugs

Avg: 24%

$312
Average prescription price

Avg: $272

SAMIR BANGALORE MD

Neurology

1,929

$430K

160
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 24%

$223
Average prescription price

Avg: $272

GOBINDER CHOPRA MD

Neurology

1,918

$494K

282
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$257
Average prescription price

Avg: $272

MARIA GREGORY MD

Neurology

1,805

$1.51M

156
72 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 24%

$838
Average prescription price

Avg: $272

WILLIAM MCHUGH MD

Neurology

1,760

$255K

182
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $272

AARON HEIDE MD

Neurology

1,638

$324K

247
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 24%

$198
Average prescription price

Avg: $272

NICOLE THEUVENET M.D.

Neurology

1,633

$410K

118
46 are 65+

17%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 24%

$251
Average prescription price

Avg: $272

JOHN LAGIOS MD

Neurology

1,632

$427K

210
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$262
Average prescription price

Avg: $272

DAVID GINSBURG M.D.

Neurology

1,351

$1.12M

134
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 24%

$830
Average prescription price

Avg: $272

STEVEN RUBIN MD

Neurology

1,316

$123K

115
45 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $272

MARGARET GOODMAN MD

Neurology

1,296

$477K

152
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 24%

$368
Average prescription price

Avg: $272

LINDA BROWN M.D.

Neurology

1,170

$475K

162
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$406
Average prescription price

Avg: $272

FRANK QUAGLIERI M.D.

Neurology

1,167

$207K

151
120 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$177
Average prescription price

Avg: $272

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank